A Double-blind Multicenter Two-arm Randomized Placebo-controlled Phase-III Clinical Study to Evaluate the Effectiveness and Safety of Thymosin α1 as an Add-on Treatment to Existing Standard of Care Treatment in Moderate-to-severe COVID-19 Patients
Sathe, Prachee, Manjunath, BG, Shetty, Adarsh, Chandrakant, Nirhali Sonali, Darnule, Rahul Ashok
Published in Indian journal of critical care medicine (01.08.2022)
Published in Indian journal of critical care medicine (01.08.2022)
Get full text
Journal Article